LLY - Eli Lilly granted exclusive license to QurAlis candidate for neurodegenerative diseases
2024-06-03 10:41:18 ET
More on Eli Lilly
- Eli Lilly's Growth And Challenges: A Cautious Buy
- Eli Lilly: Addressing Supply Challenges Should Accelerate Growth
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- SA Asks: Which weight-loss stocks should investors be watching?
- Goldman Sachs raises obesity drug market estimate to $130B